James Blachly, MD

Division of Hematology, Department of Internal Medicine, The Ohio State University James Cancer Hospital

N/A

Poster(s):

• 1004 - The PKCβ inhibitor MS-553 displays preclinical efficacy in BTK inhibitor resistant Chronic Lymphocytic Leukemia

• 1120 - Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T cell phenotypes in CLL patients treated with ibrutinib.